Evidence map›Paper›PMID 28113025›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?

Vito Amoroso, Nicola Fazio, Alessandra Mosca, Elisa Roca, Francesca Spada, Chiara Foroni, Giorgio Maria Agazzi, Alfredo Berruti

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Vito AmorosoVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Nicola FazioVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Alessandra MoscaVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Elisa RocaVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Francesca SpadaVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Chiara ForoniVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Giorgio Maria AgazziVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
Alfredo BerrutiVito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neuroendocrine TumorsPancreatic NeoplasmsBiomarkersEverolimusHumansBiomarkersEverolimus

Identifiers

PMID28113025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.